Impact Pharmaceutical Services CEO and leadership

Timothy Garver, PhD, is the Chief Scientific Officer & Chief Compliance Officer and a co-founder of IMPACT. In addition to helping manage IMPACT’s operational activities as well as its stellar staff, Tim still spends a significant amount of his time on day-to-day project work in support of IMPACT’s clients. Prior to joining IMPACT, Tim served as the Senior Director of Regulatory Affairs and Strategic Drug Development Services at SRA International and its legacy companies (Lineberry Research Associates and Constella Group). Overall, he has 17 years of medical writing, clinical research, regulatory affairs, and strategic consulting experience for both drugs and biologics.During his career, Tim has played a key role in more than 25 marketing applications (NDAs/BLAs/MAAs) across a variety of therapeutic fields, and he has extensive experience authoring all types of regulatory documents (CSRs, IBs, protocols, IND components, etc.) as well as briefing documents for both Regulatory Agency and Advisory Committee Meetings. Tim also routinely provides project management and drug development consulting services for IMPACT’s clients. Tim received his PhD in Pharmacology from Penn State University and was a Howard Hughes Medical Institute postdoctoral fellow in the Department of Biochemistry and Cell Biology at the Duke University Medical Center. In his free time, you can find Tim supporting his 3 children’s various athletic activities, hitting the pavement each morning for his daily run along the streets of Apex, spending as much time as possible on Bald Head Island, and passionately rooting for every sports team from Pittsburgh who proudly don the “Black-N-Gold”.